FDA gives nod to hemophilia kit

09/14/2004 | NYTimes.com

Wyeth Pharmaceuticals won approval for its needle-free kit that reconstitutes factor VIII, an important blood protein that helps form clots. The ReFactor Antihemophilic Factor R2 kit is intended to help patients get regular treatment more quickly and safely for the inherited blood disorder.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA